1002010.11.26

100100

96500

10031100331https://pfp.bhp.doh.gov.tw48

*

*

305530 300504020

-1. 90022.50

-100

9910010199.5.1799.1.199.4.30299.1.199.12.31101.3.15100.1.1100.12.31100.6.15100145101.6.1510114599.10.1799.5.199.9.30100.11.1 100.6.1100.9.30101.11.1101.6.1101.9.30

4(1)1 71 176 61 21 1 37l2 / 10

*-1

Rating A 10Rating A + Rating B 27Rating D + Rating E010Rating B()5Rating A Rating A + Rating B 11Rating D 3Rating E0 Rating A + Rating B 10Rating D 4Rating E 1

-2B1.22.43.23.3.33.53.6.23.6.33.104.15.1

1.11.21.31.4 2.12.2.12.2.22.32.42.52.6 3.13.23.3.13.3.23.3.33.3.43.43.53.6.13.6.23.7.13.7.23.83.93.6.33.6.43.10 4.14.24.34.44.54.6 5.15.2 6.1

*

99100210021.42.2.23.3.43.7.23.83.94.55.15.2991002

*

*

1.1 Rating E Rating D Rating C50

*

1.1Rating BC Rating AB1.275

*

1.1

*

1.1

Q A -1

Q A 106399

Q A -2

N10 N61/108[8/10*100%]=80 6[6/6*100%]=100 3/10550% 233% 5/1010100% 583% 7/10990% 6100% 9/10990% 583%11/1010100% 583% 80+100+90+90+100)/5=92% (100+83+100+83+83)/5=90%

*

1.2 1234

*

1.2Rating E Rating D Rating C Rating C

*

1.2Rating BCRating AB

*

1.21-4

*

1.2

*

1.3 Rating E Rating DRating C Rating C

*

1.3Rating BCPDCARating ABPDCA 10097-99

*

1.312

*

1.4 1. 1AJCC 2 32. 4

*

1.4 1. 1AJCC 2 3

*

1.4

*

98116C18-C21C22C33-C34C50C53C54C55C56C00 - C06C09 - C10C12 - C14 )C07-C08C11C15C16C61C67M-code9590-99922.1D2.1D1009811

*

2.1 Rating ERating DRating D Rating C

*

2.1Rating BC Rating AB3000130002

*

2.120

*

2.110097

*

2.2 2.2.1 Rating ERating DRating D95%98% 90%95% Rating C98% 95%98%

*

2.2.1Rating B98%98%95% Rating A98 96-98

*

2.2.11.991A/B100%99 A97 B97 + 97 2E+F/D100%99 D97 E9797 F9797

*

2.2.13G/H100(99) G97 H972.

*

2.2.2Rating ERating DRating D80%85%Rating C85%90%Rating B90%95%Rating A95%

*

2.2.21. I/J100 I J 2.

*

2.3 Rating E Rating DRating CRating C Rating BC() Rating AB

*

2.3

*

2.3Rating A 3 1 2 3 3.

2.3Q A QA

*

2.4 Rating E Rating DRating CRating C Rating BC Rating AB

*

2.4

*

2.41. 1234Class1~252.

2.4Q A Q1A1Q2A2

*

2.5Class1~2 Rating E Rating DRating C Rating C80

*

2.5Rating BC80~95Rating AB95

*

2.5Class1~2Stage

*

2.5123 Class1~245

*

2.51. K/L100 K L 10010%Class1-2

*

1962.13Tumor Size96983.4T Clinical T1151172.14Regional Lymph Nodes Examined991003.5N Clinical N1181193.6M Clinical M1201212.15Regional Lymph Nodes Positive1011023.7Clinical Stage Group122124

*

13.10T Pathologic T127129Other Staging System FIGO3.11N Pathologic N130131Other Staging SystemBCLC1013.12M Pathologic M132133Other Staging Systemhistology1013.13Pathologic Stage Group134136

*

2.6class0-3 Rating ERating D Rating C Rating BC Rating AB

*

2.6

*

2.61.1class 0-32class 1-225 class0334(:)56

2.6Q A Q Asummary

3.1 Rating ERating DRating CRating CRating BC

3.1Rating AB /

3.11. 1 peer review article 2 3 42. Rating A Hodgkin lymphomaBDiffuse large B cell lymphomaFollicular lymphoma

3.1Q A QRating BA

3.2 Rating ERating DRating CRating C 70 Rating BC 1. 50% 2.

3.2Rating AB 1. 2. class 1~2

3.2

class 1~2 1 2 2

3

1,00061,001-2,00092,00112

3.2

2. 1 2 33. minimum requirement12345comorbidity6 regimensdose

*

3.2

4.CB 5. summary note6. 7.

3.2Q A QCBA6

12345X6XC5/6=83%B14/667%

3.3 3.3.1 Rating E20Rating D20%40%Rating C40%60%Rating B60%80%Rating A80%

3.3.11 2()TNMAJCC

100

3.3.1

12724 11 [27+1401/ 212] 100 18/2410075 Rating B2.3.2

3.3.2 Rating E20

Rating D20%40%

Rating C40%60%

Rating B60%80%

Rating A80%

3.3.2 1 2 3()

100

3.3.2

12833211 [38+2311/ 312] 100 31/36100 86 Rating A2.3.2

3.3.3 Rating E20Rating D20%40%Rating C40%60%Rating B60%80%Rating A80% 1. 1 2 3 2. Neoadjuvant

100

3.3.3

94322 211 [34+22+12+01/ 39] 10018/2710067 Rating B2..3.2

3.3.4Rating E20Rating D20%40%Rating C40%60%Rating B60%80%Rating A80% curative intent

3.3.4curative intent1 23 1C()

100

3.3.41.

9233 2311 [32+23+13+01/ 39] 10015/2710056 Rating C2. 3.2

3.3.4Q A Q11. A1 Q2 A2 progression note

3.4 Rating ERating DRating CRating C Rating BC70%

3.4Rating AB

3.4

3.424B 150 2()

1. 2. 3. 4. 5.() 6.

7. () 8. 9. 10. 11. 12.

3.5 Rating ERating DRating CRating C 1. 2. 10%

3.5Rating BC 1. 2. 10%5% Rating AB10%20%10%

3.51.2.3. 1. 2.12303

3.5 1 2 312 3 4

3.55.1conclusion or recommendation2process6.

3.5Q A Q A

3.6 3.6.1 Rating E Rating DRating CRating C

3.6.1Rating BC

Rating AB

3.6.1 (Adjuvant)(Neoadjuvant)(Concurrent Chemoradiotherapy , CCRT)

3.6.1 1 peer review article 2 3 4

3.6.1Q A QA

3.6.2 Rating E Rating DRating CRating C 3.6.1 Prescription Rating BCPrescription Rating AB

3.6.2 1Prescription

*

3.6.3 Rating E Rating DRating CRating C Rating BC Rating AB

*

3.6.3

1.2.3.4.

*

3.6.3

1. (1)(2)(3)ready to use2.

*

3.6.3

3.4.5.

*

3.6.3

6.(spill kits)1

Class IIBClass III ()

*

3.6.3

2: () ()( )

*

3.6.4 Rating E Rating DRating CRating C Rating BC Rating AB

*

3.6.41.2. 3. 1.1 2

*

3.6.4

2.3.4.5.

6. 3.6.3

*

3.6.4

1.2.1

3.6.4Q A Qready to use2 AReady to use2

Qbarcode2Abarcode2

3.7 3.7.1 Rating ERating DRating CRating C1. 2.Rating BC Rating AB

3.7.1 1 23. permanent section

3.7.2 Rating ERating DRating CRating C Rating BC

3.7.2Rating AB

3.8 Rating E Rating DRating CRating C Rating BC Rating AB

3.8 CTMRI

3.9 Rating E Rating DRating CRating C() (curative intent) Rating BCRating C (curative intent)

3.9Rating ABRating C(curative intent) 1. 2. 3. 4.

3.91. (1) (2) CTV PTV 2.1peer review article23()4

3.93.(1)(2) 4.5.6.C7.CE

3.10 Rating E Rating DRating CRating C Rating B Rating A

*

3.10 100

*

*

4.1123/4

*

4.1Rating E Rating DRating CRating C 1. 2.

*

4.1Rating BC 1. 2. Rating AB 1. 2.

*

4.1/

*

4.11.2.Port-AHickmanPICC3./4.5.

*

4.16.7.8.3.6.4

4.1Q A QPort-APICCHickmanHickmanAQE-learningA

*

4.2 Rating E Rating DRating CRating C Rating BC Rating AB

*

4.21.2.3. 3.6.4

*

4.3 Rating E Rating DRating CRating C

*

4.3Rating B Rating A

*

4.31.2.

*

4.31.1.32.341 3.3.6.4

*

4.4Rating E Rating DRating CRating C

*

4.4Rating BC 1. 20 2. 80 20 3.

*

4.4Rating AB 1. 2.6 50%

*

4.41.()2.3.4.205.6.

*

4.41. 2. 6 6 3. 6

*

4.5 Rating E Rating DRating CRating C1.502.

*

4.5Rating BC 1.Class1~24002. Rating AB 1.2.

*

4.51.2.3.4.

*

4.51.100972.1122 3 4

*

4.53.C

*

4.6 Rating E Rating DRating CRating C Rating BC 1. 2.

*

4.6Rating AB1.2.3.4.5.

*

4.61.2.3.4.

*

4.61.2.

*

4.63.4.AintakeBMI

*

*

5.1 Rating E Rating DRating CRating C Rating BC Rating AB

*

5.1 2 PDCA

*

5.2 Rating E Rating D Rating C Rating BC Rating AB

*

5.2

5.2Q A QRating BAQA

*

*

6.1 class1~22,000A 1.IRB 2.class1~220001A

*

6.1IRB

*

3.4Q1:7.B5050241019B

Q2:55